Patents Examined by David W Berke-Schlessel
  • Patent number: 11582967
    Abstract: An aqueous storage solution for the storage of red blood cells, comprising an aqueous solution and at least one lipid, wherein the at least one lipid is effective in suppressing hemolysis in red blood cells and wherein the at least one lipid is emulsified within the aqueous solution.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: February 21, 2023
    Assignee: Fenwal, Inc.
    Inventor: Craig L. Sandford
  • Patent number: 11583519
    Abstract: A nasal composition is provided comprising or consisting of a first composition part in the form of a liquid for nasal application to a patient in use, and a second composition part in the form of a powder for nasal application to the patient in use. The first and second composition parts are applied to the patient separately or together as required.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: February 21, 2023
    Assignee: Nasaleze Patents Limited
    Inventor: Todor A. Popov
  • Patent number: 11584947
    Abstract: A method for detecting the presence of bacterial spores is described by measuring microbial metabolic activity over time. Spores are distinguished from vegetative cells and other microorganisms by detecting a burst of metabolic activity indicating germination of spores. This method may be used to detect bacterial spores in a commercial process system, such as a papermaking system within the time frame of a typical work shift.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: February 21, 2023
    Assignee: ECOLAB USA INC.
    Inventors: Liliya Lund, Laura Rice
  • Patent number: 11576857
    Abstract: Methods and compositions for delivering medicine and other substances to the brain and the body via the cribriform plate using foamable compositions are described. Methods and compositions for improving nasal hygiene and moisturizing the nasal cavity using foamable compositions are also described.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: February 14, 2023
    Inventor: Sanjay Gupta
  • Patent number: 11577062
    Abstract: Embodiments of the present disclosure encompass systems and methods for in-situ/in vivo, bottom-up tissue generation for wound repair, repair of tissue defects, and the like. Embodiments of the systems of the present disclosure include modular scaffolds seeded with cells (modular tissue forming units (MTFUs)) for packing a tissue defect, such that these MTFUs are able to fill the wound bed with cells of one or more needed tissue types supported by the modular scaffolding particles.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: February 14, 2023
    Assignee: University of Florida Research Foundation, Inc.
    Inventor: Adam J. Katz
  • Patent number: 11571449
    Abstract: The present invention provides a pharmaceutical composition including a probiotic and a prebiotic for treatment of stunting in children. More particularly, the pharmaceutical composition includes at least one Lactobacillus specie(s) as a probiotic and at least one oligosaccharide as a prebiotic. The present invention further provides a method of treatment of stunting including administering an effective amount of a pharmaceutical composition including a probiotic and a prebiotic to children in need thereof.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: February 7, 2023
    Assignee: Chr. Hansen A/S
    Inventor: Pravas Ranjan Misra
  • Patent number: 11564785
    Abstract: The invention provides compositions that include isolated, non-pathogenic, hydrogen peroxide-producing bacterial strains and genetically engineered LDH-deficient bacterial strains, which can be used to whiten teeth and treat periodontal disease.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: January 31, 2023
    Assignee: ProBiora Health, LLC
    Inventor: Jeffrey Daniel Hillman
  • Patent number: 11560544
    Abstract: The present invention concerns a process for isolating an archaeon of the order of commensal clade Methanomassiliicoccales, the use of a culture and/or isolation medium comprising a sterile extract of a bacterial culture of a bacterium of genus Eggerthella, for the isolation and/or culture of an archaeon of the order of commensal clade Methanomassiliicoccales, and a pure, isolated archaeon Methanomethylophilus alvus Mx-05. It also concerns a culture method of an archaeon of the order of commensal clade Methanomassiliicoccales.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: January 24, 2023
    Assignees: LESAFFRE ET COMPAGNIE, UNIVERSITÉ CLERMONT AUVERGNE, INSTITUT DE RECHERCHE POUR LE DÉVELOPPMENT
    Inventors: Wajdi Ben Hania, Jean-François Brugere, Marie-Laure Fardeau, Bernard Ollivier
  • Patent number: 11559554
    Abstract: A composition composed of xylooligosaccharide, arabinogalactan, inulin, Ganoderma lucidum beta glucan, insoluble yeast ? (1, 3/1, 6)-glucan, soluble oat ? (1,3/1, 4)-glucan, and insoluble dried Saccharomyces cerevisiae fermentate, with a Bacillus coagulans component, for use in improving or maintaining digestive health, weight and glucose balance and boosting immunity is provided.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: January 24, 2023
    Assignee: KIBOW BIOTECH INC.
    Inventor: Natarajan Ranganathan
  • Patent number: 11559483
    Abstract: Methods and compositions for delivering medicine and other substances to the brain and the body via the cribriform plate using foamable compositions are described. Methods and compositions for improving nasal hygiene and moisturizing the nasal cavity using foamable compositions are also described.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: January 24, 2023
    Inventor: Sanjay Gupta
  • Patent number: 11555157
    Abstract: A method of producing liquid fuel and/or chemicals from a carbonaceous material entails combusting a conditioned syngas in pulse combustion heat exchangers of a steam reformer to help convert carbonaceous material into first reactor product gas which includes carbon monoxide, hydrogen, carbon dioxide and other gases. A portion of the first reactor product gas is transferred to a hydrogen reformer into which additional conditioned syngas is added and a reaction carried out to produce an improved syngas. The improved syngas is then subject to one or more gas clean-up steps to form a new conditioned syngas. A portion of the new conditioned syngas is recycled to be used as the conditioned syngas in the pulse combustion heat exchangers and in the hydrocarbon reformer. A system for carrying out the method include, a steam reformer, a hydrocarbon reformer, first and second gas-cleanup systems, a synthesis system and an upgrading system.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: January 17, 2023
    Assignee: ThermoChem Recovery International, Inc.
    Inventors: Ravi Chandran, Dave G. Newport, Daniel A. Burciaga, Daniel Michael Leo, Justin Kevin Miller, Brian Christopher Attwood
  • Patent number: 11548802
    Abstract: A composition for remediation of soil and groundwater containing halogenated compounds. The remediation composition includes an elemental iron-based composition, which may include activated carbon capable of absorbing the halogenated compounds with numerous pores impregnated with elemental iron. The remediation composition further includes a first bioremediation material including a blend of one-to-many organisms capable of degrading the halogenated compounds. The remediation composition includes an organic compound or polymeric substance and a second bioremediation material including a blend of one-to-many organisms capable of degrading the organic compound or polymeric substance over time (e.g., 20 to 365 or more days to provide a time release substrate-creating material or platform) into smaller molecules or compounds used by the organisms in the first bioremediation material while degrading the halogenated compounds.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: January 10, 2023
    Assignee: Remediation Products, Inc.
    Inventor: Scott Noland
  • Patent number: 11549100
    Abstract: A method of producing a cell mass by three-dimensional culture of primary cancer cells having proliferative ability and properties of handleability, versatility, and high-throughput performance, in which a tumor tissue is used as a starting material, proliferation of cells such as fibroblasts other than cancer cells is inhibited, and the cell mass includes primary cancer cells as a main component. The object is achieved by providing a method of producing a cell mass by three-dimensional culture of primary cancer cells using a tumor tissue, including: a three-dimensional culture step of culturing cells obtained from the tumor tissue in a medium containing a 5% v/v or less extracellular matrix on a substantially low-adhesive cell culture substrate.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: January 10, 2023
    Assignee: LSI MEDIENCE CORPORATION
    Inventors: Hideaki Kakinuma, Yukiko Shimada, Hiroaki Inoue, Takashi Morikawa
  • Patent number: 11548785
    Abstract: The invention is directed to a control method for a process to convert bisulphide to elemental sulphur in an aqueous solution comprising sulphide-oxidising bacteria wherein the process is controlled by applying a potential between the anode electrode and the cathode electrode or between the anode electrode and the reference electrode of an electrochemical cell resulting in a current between the cathode electrode and the anode electrode, measuring a current as measured by an electrochemical cell and adapting the process in response to the measured current. The process to convert bisulphide may comprise the following steps: (a) contacting bisulphide with oxidised sulphide-oxidising bacteria in the aqueous solution and elemental sulphur, (b) oxidizing the reduced sulphide-oxidising bacteria, (c) using the oxidised sulphide-oxidising bacteria obtained in step (b) in step (a) and (d) isolating elemental sulphur from the aqueous solution obtained in step (a) and/or step (b).
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: January 10, 2023
    Assignee: PAQELL B.V.
    Inventors: Johannes Bernardus Maria Klok, Annemiek Ter Heijne, Frederikus De Rink, Cees Jan Nico Buisman
  • Patent number: 11535880
    Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: December 27, 2022
    Assignee: ENSOVI, INC.
    Inventors: Kyle A. Minor, Carlo D. Montemagno, David W. Wendell
  • Patent number: 11523614
    Abstract: A water soluble granule (SG) of Bacillus velezensis, including 0.1-97 parts by weight of the stock powder of B. velezensis or/and its secondary metabolic active bacteriostatic substances, 1-5 parts by weight of a binder, 1-10 parts by weight of a disintegrant, 1-5 parts by weight of a dispersant, and other filler making up to 100 parts by weight. The soluble granule of B. velezensis has advantages of good storage resistance, easy use, strong activity and high safety.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: December 13, 2022
    Inventor: Zhijun Lu
  • Patent number: 11511017
    Abstract: The present disclosure describes methods of treating a ligament injury with ligament grafting.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: November 29, 2022
    Assignee: ARTHREX, INC.
    Inventors: David O. Shepard, Robert Harrison, Robert Benedict
  • Patent number: 11485948
    Abstract: The present invention relates to a process for depositing at least a culture of microorganisms to an elongated element, preferably a yarn, comprising the steps of: providing at least a first feeding device comprising at least a first outlet; supplying at least one elongated element to said at least first feeding device; feeding to said first outlet at least a first culture comprising at least one microorganism; dispensing said first culture from said at least first outlet; contacting at least part of said elongated element with said first culture of microorganisms, to provide at least a part of said elongated element with an amount of said first culture of microorganisms.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: November 1, 2022
    Assignee: Sanko Tekstil Isletmeleri San. Ve Tic. A.S.
    Inventors: Jitka Eryilmaz, Ece Senel, Seref Agzikara, Nejdiye Gunes, Fehim Caglar, Semih Kazanc, Ozgur Cobanoglu
  • Patent number: 11479746
    Abstract: The disclosure relates to methods, systems and compositions for use in the production of milk. More specifically, the disclosure is directed to systems, compositions and methods for in-vitro production of milk using an array of mammary organoids seeded on tertiary-branched, resilient duct scaffolding.
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: October 25, 2022
    Assignee: Biomilk Ltd.
    Inventor: Sharon Fima
  • Patent number: 11473053
    Abstract: A hydrogel capsule comprising a stem cell core that has been induced to differentiate into a hematopoietic lineage cell, and methods for the production of hematopoietic lineage cells from stem cells encapsulated in a hydrogel.
    Type: Grant
    Filed: October 31, 2019
    Date of Patent: October 18, 2022
    Assignee: PLASTICELL LTD.
    Inventors: Marina Tarunina, Cedric Humbert, Shahzad Ali, Yen Choo, Aaron Tsu Tshen Chuang, Dennis Saw